Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q9HM
|
|||
| Former ID |
DNCL003110
|
|||
| Drug Name |
CM-AT
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z] | Phase 3 | [1] | |
| Autism spectrum disorder [ICD-11: 6A02; ICD-10: F84.0] | Phase 3 | [1] | ||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Chymotrypsin (CTR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00881452) A Trial of CM-AT in Children With Autism. U.S. National Institutes of Health. | |||
| REF 2 | Drugmakers dance with autism. Nat Biotechnol. 2010 Aug;28(8):772-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.